Menu Search
Equities

Jolt Health Inc

JTHTF:PKC

Jolt Health Inc

Actions
  • Price (USD)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jolt Health Inc. is a Canada-based life sciences company focused on healthcare, biotechnology and artificial intelligence. The Company holds licenses for therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America. The Company's Wellness Product Portfolio is comprised of wellness products and the underlying intellectual property, concentrating on sexual health, with or without the benefit of CBD, acquired pursuant to various product licenses. In particular, the Company has rights to utilize a range of products and the related intellectual property pursuant to the product licenses, including CBD oral strips, Arouse RX gel with CBD and/or THC, CBD/THC biphasic mints/candies, Female Sexual Dysfunction supplement (FSD Supplement), ToConceive, and Male Enhancement Gel With CBD.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-2.63m
  • Incorporated2021
  • Employees--
  • Location
    Jolt Health Inc#430 - 580 Hornby StreetVANCOUVER V6C 3B6CanadaCAN
  • Phone+1 (604) 568-0149
  • Websitehttps://jolt-health.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.